Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1986)
Frequenza di sieroconversioni per parvovirus urnano in u n gruppo di donatori di sangue
K. Ozawa, G. Kurtzman, N. Young (1986)
Replication of the B19 parvovirus in human bone marrow cell cultures.Science, 233 4766
P. Mortimer, N. Luban, J. Kelleher, B. Cohen (1983)
TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 322
G. Siegl, R. Bates, K. Berns, B. Carter, D. Kelly, E. Kurstak, P. Tattersall (1985)
Characteristics and taxonomy of Parvoviridae.Intervirology, 23 2
P. Mortimer, R. Humphries, J. Moore, R. Purcell, N. Young (1983)
A human parvovirus-like virus inhibits haematopoietic colony formation in vitroNature, 302
J. Craske, P. Kirk, B. Cohen, E. Vandervelde (1978)
Commercial factor VIII associated hepatitis, 1974–75, in the United Kingdom: a retrospective surveyJournal of Hygiene, 80
D. Carrington, M. Whittle, A. Gibson, T. Brown, A. Field, D. Gilmore, D. Aitken, W. Patrick, E. Caul, J. Clewley, B. Cohen (1987)
MATERNAL SERUM α-FETOPROTEIN—A MARKER OF FETAL APLASTIC CRISIS DURING INTRAUTERINE HUMAN PARVOVIRUS INFECTIONThe Lancet, 329
C. Ludlam, C. Steel, R. Cheingsong-Popov, D. Mcclelland, J. Tucker, R. Tedder, R. Weiss, I. Philp, R. Prescott (1985)
HUMAN T-LYMPHOTROPIC VIRUS TYPE III (HTLV-III) INFECTION IN SERONEGATIVE HAEMOPHILIACS AFTER TRANSFUSION OF FACTOR VIIIThe Lancet, 326
K. Schimpf, P. Mannucci, W. Kreutz, H. Bragkmann, C. Auerswald, Nicola Ciavarella, J. Mößeler, V. Derosa, B. Kraus, Ch. Bruegkmann, G. Mancuso, U. Mittler, F. Haschke, Massimo Morfini (1987)
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.The New England journal of medicine, 316 15
M. Anderson, M. Anderson, S. Jones, A. Minson (1985)
Diagnosis of human parvovirus infection by dot‐blot hybridization using cloned viral DNAJournal of Medical Virology, 15
D. White, D. White, P. Mortimer, P. Mortimer, D. Blake, D. Blake, A. Woolf, A. Woolf, B. Cohen, B. Cohen, P. Bacon, P. Bacon (1985)
HUMAN PARVOVIRUS ARTHROPATHYThe Lancet, 325
P. Kernoff, C. Lee, P. Karayiannis, H. Thomas (1985)
High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinBritish Journal of Haematology, 60
R. Dei, P. Urbano (1982)
Immunoelectroosmophoresis for the human papovavirus BK.Journal of virological methods, 3 6
M. Morfini, D. Rafanelli, G. Longo, A. Messori, P. Ferrini (1986)
Hepatitis-Free Interval After Clotting Factor Therapy in First Infused HaemophiliacsThrombosis and Haemostasis, 56
Prevalenza di anticorpi anti-parvovirus umano nella popolazione infantile Italiana
O. Corsi, A. Azzi (1986)
Human parvovirus specific IgM in antigen positive serum.Journal of Clinical Pathology, 39
B. Cohen, P. Mortimer, M. Pereira (1983)
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV)Journal of Hygiene, 91
G. Siegl (1976)
The ParvovirusesVirology monographs. Die Virusforschung in Einzeldarstellungen, 15
Kernoff Kernoff, Lee Lee, Karayannis Karayannis, Thomas Thomas (1984)
High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: Effect of pooled human immunoglobulinBritish Journal of Haematology, 58
Anderson Anderson, Pattison Pattison (1984)
The human parvovirusArchives of Virology, 82
A group of 27 first infused haemophiliacs was studied for association between heat‐treated clotting factor concentrates and transmission of human parvovirus B19. The prevalence rate of B19 antibody, detected by the Immunoelectroosmophoresis (IEOP) reaction, was 55.5% in this group of first infused subjects, significantly higher than the 29.3% of the control group of 58 healthy blood donors but lower than the 93.3% of antibody positive subjects in a group of 30 haemophiliacs multitreated with unheated products. Five of 17 B19 antibody negative patients produced human parvovirus IgM, detectable by radioimmunoassay, after the first treatment with heated concentrates; two of them developed viraemia 6 and 10 days, respectively, after the first infusion dose. These results lead to the conclusion that human parvovirus is transmissible by blood derivatives even when they have been exposed to steam‐ or dry‐heat treatment.
Journal of Medical Virology – Wiley
Published: Jun 1, 1988
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.